Dear DEKA Stakeholders,
The year 2022 was another exceptional year from the standpoint of our own brand products, with sales which underscore a total growth of over 30% compared to 2021.
The above stems from the quality and reliability of our products, their superior clinical value, and new distributive choices, where DEKA is endorsing interlocutors which are ever more dedicated to their own brand, but who are also rather structured, both from the standpoint of sales and technical support, as well as with regards to training offer and avantgarde post-sale services.
Almost every market has registered a very positive mark in relation to business development.
This has also been possible thanks to Research and Development, which has been able to strongly react to negative phenomena which have impacted the supply chain sphere.
The European MDR regulation has represented a strong obstacle to the development of new products and new technologies in the aesthetic sector in the last 24 months, not only for DEKA, but at the end of the year 2022 the European Commission finally signed off on the so-called Common Specifications of the notorious Attachment XVI, and now we certainly face a brighter horizon for the development of our products.
Already from H2 2023, some surprises to such regard will be unveiled.
Our area managers’ activity has been relentless, and they all reached positive results.
In Italy we are the absolute Number One, thanks to a phenomenal network of direct agencies with a capillary coverage in the territory.
Our CPR division (Clinical Practice and Research), with our internal photo-biological laboratory and several external interlocutors, has looked after the assistance of the realization of several clinical studies, which have, on one hand, contributed to the realization of scientific publications in high-impact- factor international magazines, and on the other, they have given even more credibility to our products, as well as to the results they guarantee.
The United States has absolutely been the most performing market for DEKA. Cartessa Aesthetics, with its President, Gabe Lubin, is doing an excellent job, and is growing strongly.
In 2023 we are opening up to new markets, for the aesthetic area but also for the surgical realm, both from a geographical and applications perspectives, with excellent partners.
Thanks to our precious contribution, and that of our numerous Key Opinion Leaders worldwide, we confidently look forward to the future, with determination, great ideas and the ability to realize
them.
Paolo Salvadeo
CEO of DEKA
General Manager of El.En.
